Management of multivessel coronary disease during primary percutaneous coronary intervention (PCI) remains controversial. Current guidelines recommend treating the infarct-related artery.
We assessed the management and outcomes of non-ST segment elevation myocardial infarction (NSTEMI) patients randomly assigned to fractional flow reserve (FFR)-guided management or angiography-guided standard care.
In age-matched women and men with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) with everolimus-eluting stents (ESS).
For the TASMIN-SR trial, Richard J. McManus, FRCGP, and colleagues studied 552 patients aged 35 years and older with baseline systolic BP ?130 mm Hg/diastolic BP ?80 mm Hg who had a history of stroke, CHD, diabetes or chronic kidney disease.
Данный сайт и вся информация на нём предназначена для медицинских работников.
Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.